5 Key Takeaways
-
1
Dr. Friedman advocates for personalized glaucoma care using genetics, patient-reported outcomes, and technology to tailor management to individual needs.
-
2
Around half of glaucoma patients in the US remain undiagnosed, highlighting the need for improved identification and monitoring strategies.
-
3
Advancements in artificial intelligence and imaging can help close the gap in glaucoma diagnosis and treatment.
-
4
Personalized care should consider the emotional and functional impacts of glaucoma on patients, beyond just preventing blindness.
-
5
Future glaucoma management will increasingly rely on genetic profiling to tailor therapies and improve patient outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.